Literature DB >> 6805007

Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations.

F A Wiesel, G Alfredsson, M Ehrnebo, G Sedvall.   

Abstract

Sulpiride (100 mg) was administered intravenously and orally to healthy human subjects. Serum concentrations of sulpiride and prolactin were followed for 36 h. Both routes of drug administration resulted in a pronounced and sustained increase in serum prolactin concentration. The prolactin response was positively correlated to the prolactin baseline value. The concentrations of prolactin remained at an elevated plateau for 9--36 h after drug treatment despite low drug concentrations. The level of this plateau was directly related to the normal circadian secretion of prolactin. The sustained prolactin elevation may be due to high affinity and strong binding of the compound to the regulating receptors or the formation of an active sulpiride metabolite. Prolactin and sulpiride concentrations were significantly correlated during the initial phase after intravenous sulpiride. Following intravenous and oral sulpiride the area under the concentration-time curve (AUC) for prolactin was similar despite a considerable difference in the sulpiride concentration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805007     DOI: 10.1007/BF00430753

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa.

Authors:  R W Turkington
Journal:  Arch Intern Med       Date:  1972-09

2.  Serum prolactin levels in unmedicated schizophrenic patients.

Authors:  H Y Meltzer; E J Sachar; A G Frantz
Journal:  Arch Gen Psychiatry       Date:  1974-10

3.  Prolactin releasing effect of sulpiride isomers in rats and man.

Authors:  E E Müller; E Stefanini; F Camanni; V Locatelli; F Massara; P F Spano; D Cocchi
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

4.  Induction of prolactin release by LRF and LRF-agonist.

Authors:  S S Yem; J D Hoff; B L Lasley; R F Casper; K Sheehan
Journal:  Life Sci       Date:  1980-06-09       Impact factor: 5.037

5.  Metabolism of sulpiride in man and rhesus monkeys.

Authors:  A R Imondi; A S Alam; J J Brennan; L M Hagerman
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-03

6.  The effect of neuroleptics on serum prolactin in schizophrenic patients.

Authors:  H Y Meltzer; V S Fang
Journal:  Arch Gen Psychiatry       Date:  1976-03

7.  Effect of sulpiride on monoaminergic mechanisms in psychotic women.

Authors:  L Bjerkenstedt; C Härnryd; G Sedval
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

8.  Stimulation of human prolactin secretion by sulpiride.

Authors:  Y Kato; S Ohgo; K Chihara; H Imura
Journal:  Endocrinol Jpn       Date:  1975-10

9.  Effects of sulpiride isomers on the control of anterior pituitary secretion in normal man.

Authors:  L F Agnati; P Cortelli; E De Camillis; F Benfenati; F Orlandi; P Fresia
Journal:  Neurosci Lett       Date:  1979-12       Impact factor: 3.046

Review 10.  Control of prolactin secretion in mammals.

Authors:  J A Clemens; C J Shaar
Journal:  Fed Proc       Date:  1980-06
View more
  8 in total

1.  Influence of the dosing interval on prolactin release after remoxipride.

Authors:  G Movin-Osswald; M Hammarlund-Udenaes; C Von Bahr; P Eneroth; K Walton-Bowen
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

2.  A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.

Authors:  P de Koning; M H de Vries
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

3.  Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers.

Authors:  Mitul A Mehta; Facundo F Manes; Gianna Magnolfi; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

4.  Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work.

Authors:  R Cools; M J Frank; A Westbrook; R van den Bosch; J I Määttä; L Hofmans; D Papadopetraki
Journal:  Science       Date:  2020-03-20       Impact factor: 47.728

5.  Single dose human pharmacology of umespirone.

Authors:  R L Holland; K Wesnes; B Dietrich
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Dopamine and memory dedifferentiation in aging.

Authors:  Hunar Abdulrahman; Paul C Fletcher; Edward Bullmore; Alexa M Morcom
Journal:  Neuroimage       Date:  2015-03-21       Impact factor: 6.556

7.  Effects of dopamine D2/D3 receptor antagonism on human planning and spatial working memory.

Authors:  M Naef; U Müller; A Linssen; L Clark; T W Robbins; C Eisenegger
Journal:  Transl Psychiatry       Date:  2017-04-25       Impact factor: 6.222

8.  Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study.

Authors:  Alexa M Morcom; Edward T Bullmore; Felicia A Huppert; Belinda Lennox; Asha Praseedom; Helen Linnington; Paul C Fletcher
Journal:  Cereb Cortex       Date:  2009-07-22       Impact factor: 5.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.